Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Systemic Immuno-inflammatory Factors in Resectable Pancreatic Adenocarcinoma

NCT05025371 is registered in ClinicalTrials.gov with Iuliu Hatieganu University of Medicine and Pharmacy as lead sponsor.

NCT NCT05025371
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05025371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Systemic Immuno-inflammatory Factors in Resectable Pancreatic Adenocarcinoma
Lead sponsor
Iuliu Hatieganu University of Medicine and Pharmacy
Phase
Observational
Overall status
Completed
Start date
April 1, 2021
Completion date
August 1, 2021
Enrollment
312 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreas cancer, duct cell adenocarcinoma